145 related articles for article (PubMed ID: 8320153)
21. NTP Toxicology and Carcinogenesis Studies of 3,4-Dihydrocoumarin (CAS No. 119-84-6) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Sep; 423():1-336. PubMed ID: 12616288
[TBL] [Abstract][Full Text] [Related]
22. Effects of a prostaglandin E1 analogue, misoprostol, on renal function in dogs receiving nephrotoxic doses of gentamicin.
Davies C; Forrester SD; Troy GC; Saunders GK; Shell LG; Johnston SA
Am J Vet Res; 1998 Aug; 59(8):1048-54. PubMed ID: 9706212
[TBL] [Abstract][Full Text] [Related]
23. [Studies on the mechanisms of renal damages induced by nephrotoxic compounds].
Yamada T
Nihon Hoigaku Zasshi; 1995 Dec; 49(6):447-57. PubMed ID: 8583688
[TBL] [Abstract][Full Text] [Related]
24. Magnesium depletion enhances cisplatin-induced nephrotoxicity.
Lajer H; Kristensen M; Hansen HH; Nielsen S; Frøkiaer J; Ostergaard LF; Christensen S; Daugaard G; Jonassen TE
Cancer Chemother Pharmacol; 2005 Nov; 56(5):535-42. PubMed ID: 15947931
[TBL] [Abstract][Full Text] [Related]
25. Clinical Evaluation of Tavocept to Decrease Diuresis Time and Volume in Dogs with Bladder Cancer Receiving Cisplatin.
Henry CJ; Flesner BK; Bechtel SA; Bryan JN; Tate DJ; Selting KA; Lattimer JC; Bryan ME; Grubb L; Hausheer F
J Vet Intern Med; 2018 Jan; 32(1):370-376. PubMed ID: 29080252
[TBL] [Abstract][Full Text] [Related]
26. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
27. Biodegradable cisplatin polymer in limb-sparing surgery for canine osteosarcoma.
Withrow SJ; Liptak JM; Straw RC; Dernell WS; Jameson VJ; Powers BE; Johnson JL; Brekke JH; Douple EB
Ann Surg Oncol; 2004 Jul; 11(7):705-13. PubMed ID: 15231525
[TBL] [Abstract][Full Text] [Related]
28. Pharmacokinetics, effects on renal function, and potentiation of atracurium-induced neuromuscular blockade after administration of a high dose of gentamicin in isoflurane-anesthetized dogs.
Martinez EA; Mealey KL; Wooldridge AA; Mercer DE; Cooper J; Slater MR; Hartsfield SM
Am J Vet Res; 1996 Nov; 57(11):1623-6. PubMed ID: 8915441
[TBL] [Abstract][Full Text] [Related]
29. Reversal of cisplatin-induced carnitine deficiency and energy starvation by propionyl-L-carnitine in rat kidney tissues.
Aleisa AM; Al-Majed AA; Al-Yahya AA; Al-Rejaie SS; Bakheet SA; Al-Shabanah OA; Sayed-Ahmed MM
Clin Exp Pharmacol Physiol; 2007 Dec; 34(12):1252-9. PubMed ID: 17973863
[TBL] [Abstract][Full Text] [Related]
30. Cisplatin: a review of toxicities and therapeutic applications.
Barabas K; Milner R; Lurie D; Adin C
Vet Comp Oncol; 2008 Mar; 6(1):1-18. PubMed ID: 19178659
[TBL] [Abstract][Full Text] [Related]
31. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
[TBL] [Abstract][Full Text] [Related]
32. Comparison of the iv and ip routes of administration of cisplatin in dogs.
Pretorius RG; Petrilli ES; Kean CK; Ford LC; Hoeschele JD; Lagasse LD
Cancer Treat Rep; 1981; 65(11-12):1055-62. PubMed ID: 7197584
[TBL] [Abstract][Full Text] [Related]
33. Gentamicin pharmacokinetics and nephrotoxicity in naturally acquired and experimentally induced disease in dogs.
Frazier DL; Aucoin DP; Riviere JE
J Am Vet Med Assoc; 1988 Jan; 192(1):57-63. PubMed ID: 3343180
[TBL] [Abstract][Full Text] [Related]
34. Toxicoses associated with the administration of mitoxantrone to dogs with malignant tumors: a dose escalation study.
Ogilvie GK; Moore AS; Chen C; Ciekot PA; Atwater SW; Bergman PJ; Walters LM
J Am Vet Med Assoc; 1994 Aug; 205(4):570-3. PubMed ID: 7961092
[TBL] [Abstract][Full Text] [Related]
35. Cisplatin therapy in 41 dogs with malignant tumors.
Knapp DW; Richardson RC; Bonney PL; Hahn K
J Vet Intern Med; 1988; 2(1):41-6. PubMed ID: 3221354
[TBL] [Abstract][Full Text] [Related]
36. Toxicoses associated with administration of mitoxantrone to dogs with malignant tumors.
Ogilvie GK; Obradovich JE; Elmslie RE; Vail DM; Moore AS; Curtis CR; Straw RC; Dickinson K; Cooper MF; Withrow SJ
J Am Vet Med Assoc; 1991 May; 198(9):1613-7. PubMed ID: 2061176
[TBL] [Abstract][Full Text] [Related]
37. NTP Toxicology and Carcinogenesis Studies of Pentachloroanisole (CAS No. 1825-21-4) in F344 Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Apr; 414():1-284. PubMed ID: 12616284
[TBL] [Abstract][Full Text] [Related]
38. Direct amifostine effect on renal tubule cells in rats.
Weichert-Jacobsen KJ; Bannowski A; Küppers F; Loch T; Stöckle M
Cancer Res; 1999 Jul; 59(14):3451-3. PubMed ID: 10416609
[TBL] [Abstract][Full Text] [Related]
39. Ontogenic aspects of cisplatin-induced nephrotoxicity in rats.
Ali BH; Al-Moundhri M; Tageldin M; Al Husseini IS; Mansour MA; Nemmar A; Tanira MO
Food Chem Toxicol; 2008 Nov; 46(11):3355-9. PubMed ID: 18790000
[TBL] [Abstract][Full Text] [Related]
40. NTP Toxicology and Carcinogenesis Studies of 4,4'-Thiobis(6- t -butyl- m -cresol) (CAS No. 96-69-5) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1994 Dec; 435():1-288. PubMed ID: 12595928
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
